A molecular model for neurodevelopmental disorders

Translational Psychiatry

Volumn 5, Issue 5, 2015, Pages

  Gigek, C O ^a,b   Chen, E S ^a,b   Ota, V K ^a,b   Maussion, G ^a   Peng, H ^a   Vaillancourt, K ^a   Diallo, A B ^a   Lopez, J P ^a   Crapper, L ^a   Vasuta, C ^a   Chen, G G ^a   Ernst, C ^a  

^a MCGILL UNIVERSITY   (Canada)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EHMT1 PROTEIN; METHYL CPG BINDING PROTEIN; METHYL CPG BINDING PROTEIN 5; MICRORNA; SHORT HAIRPIN RNA; SPECIAL AT RICH BINDING PROTEIN 2; TCF4 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; MATRIX ATTACHMENT REGION BINDING PROTEIN; MBD5 PROTEIN, HUMAN; SATB2 PROTEIN, HUMAN;

ARTICLE; CELL PROLIFERATION; CHROMOSOME DELETION; CHROMOSOME DELETION 2Q23; CHROMOSOME DELETION 2Q33; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; FETUS; GENE DOSAGE; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETIC VARIATION; HUMAN; HUMAN CELL; MENTAL DISEASE; MOLECULAR MODEL; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; PROTEIN EXPRESSION; RNA SEQUENCE; RNA STABILITY; CELL CULTURE; CELL DIFFERENTIATION; CHROMOSOME 2; GENETIC EPIGENESIS; GENETICS; HIGH THROUGHPUT SEQUENCING; METABOLISM; NERVOUS SYSTEM DEVELOPMENT; SEQUENCE ANALYSIS;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 2; DNA METHYLATION; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; GENE DOSAGE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MATRIX ATTACHMENT REGION BINDING PROTEINS; MICRORNAS; MODELS, MOLECULAR; NEURAL STEM CELLS; NEURODEVELOPMENTAL DISORDERS; NEUROGENESIS; SEQUENCE ANALYSIS, RNA; TRANSCRIPTION FACTORS;

EID: 84990937732     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2015.56     Document Type: Article

References (81)

1. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999; 23: 185-188.
2. Hinds HL, Ashley CT, Sutcliffe JS, Nelson DL, Warren ST, Housman DE et al. Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nat Genet 1993; 3: 36-43.
3. Schanen NC. Epigenetics of autism spectrum disorders. Hum Mol Genet 2006; 15, Spec No 2 R138-R150.
4. Bernier R, Golzio C, Xiong B, Stessman HA, Coe BP, Penn O et al. Disruptive CHD8 mutations define a subtype of autism early in development. Cell 2014; 158: 263-276.
5. Talkowski ME, Rosenfeld JA, Blumenthal I, Pillalamarri V, Chiang C, Heilbut A et al. Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell 2012; 149: 525-537.
6. Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg IC et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003; 34: 27-29.
7. Cline H. Synaptogenesis: A balancing act between excitation and inhibition. Curr Biol 2005; 15: R203-R205.
8. Ebrahimi-Fakhari D, Sahin M. Autism and the synapse: Emerging mechanisms and mechanism-based therapies. Curr Opin Neurol 2015; 28: 91-102.
9. Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 2007; 39: 25-27.
10. Bena F, Bruno DL, Eriksson M, van Ravenswaaij-Arts C, Stark Z, Dijkhuizen T et al. Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature. Am J Med Genet B Neuropsychiatr Genet 2013; 162B: 388-403.
11. Gkogkas CG, Khoutorsky A, Ran I, Rampakakis E, Nevarko T, Weatherill DB et al. Autism-related deficits via dysregulated eIF4E-dependent translational control. Nature 2013; 493: 371-377.
12. Kelleher RJ 3rd, Bear MF. The autistic neuron: Troubled translation? Cell 2008; 135: 401-406.
13. Kalkman HO. A review of the evidence for the canonical Wnt pathway in autism spectrum disorders. Mol Autism 2012; 3: 10.
14. Krumm N, O'Roak BJ, Shendure J, Eichler EE. A de novo convergence of autism genetics and molecular neuroscience. Trends Neurosci 2014; 37: 95-105.
15. Talkowski ME, Mullegama SV, Rosenfeld JA, van Bon BW, Shen Y, Repnikova EA et al. Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder. Am J Hum Genet 2011; 89: 551-563.
16. Wu H, Zeng H, Lam R, Tempel W, Amaya MF, Xu C et al. Structural and histone binding ability characterizations of human PWWP domains. PLoS One 2011; 6: E18919.
17. Stec I, Nagl SB, van Ommen GJ, den Dunnen JT. The PWWP domain: A potential protein-protein interaction domain in nuclear proteins influencing differentiation? FEBS Lett 2000; 473: 1-5.
18. van Bon BW, Koolen DA, Brueton L, McMullan D, Lichtenbelt KD, Ades LC et al. The 2q23.1 microdeletion syndrome: Clinical and behavioural phenotype. Eur J Hum Genet 2010; 18: 163-170.
19. Jaillard S, Dubourg C, Gerard-Blanluet M, Delahaye A, Pasquier L, Dupont C et al. 2q23.1 microdeletion identified by array comparative genomic hybridisation: An emerging phenotype with Angelman-like features? J Med Genet 2009; 46: 847-855.
20. Williams SR, Mullegama SV, Rosenfeld JA, Dagli AI, Hatchwell E, Allen WP et al. Haploinsufficiency of MBD5 associated with a syndrome involving microcephaly, intellectual disabilities, severe speech impairment, and seizures. Eur J Hum Genet 2010; 18: 436-441.
21. Britanova O, Akopov S, Lukyanov S, Gruss P, Tarabykin V. Novel transcription factor Satb2 interacts with matrix attachment region DNA elements in a tissuespecific manner and demonstrates cell-type-dependent expression in the developing mouse CNS. Eur J Neurosci 2005; 21: 658-668.
22. Alcamo EA, Chirivella L, Dautzenberg M, Dobreva G, Farinas I, Grosschedl R et al. Satb2 regulates callosal projection neuron identity in the developing cerebral cortex. Neuron 2008; 57: 364-377.
23. Gyorgy AB, Szemes M, de Juan Romero C, Tarabykin V, Agoston DV. SATB2 interacts with chromatin-remodeling molecules in differentiating cortical neurons. Eur J Neurosci 2008; 27: 865-873.
24. Rosenfeld JA, Ballif BC, Lucas A, Spence EJ, Powell C, Aylsworth AS et al. Small deletions of SATB2 cause some of the clinical features of the 2q33.1 microdeletion syndrome. PLoS One 2009; 4: E6568.
25. FitzPatrick DR, Carr IM, McLaren L, Leek JP, Wightman P, Williamson K et al. Identification of SATB2 as the cleft palate gene on 2q32-q33. Hum Mol Genet 2003; 12: 2491-2501.
26. Usui D, Shimada S, Shimojima K, Sugawara M, Kawasaki H, Shigematu H et al. Interstitial duplication of 2q32.1-q33.3 in a patient with epilepsy, developmental delay, and autistic behavior. Am J Med Genet A 2013; 161A: 1078-1084.
27. Trapnell C, Pachter L, Salzberg SL. TopHat: Discovering splice junctions with RNA-Seq. Bioinformatics 2009; 25: 1105-1111.
28. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 2009; 10: R25.
29. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 2012; 7: 562-578.
30. Chen GG, Diallo AB, Poujol R, Nagy C, Staffa A, Vaillancourt K et al. BisQC: An operational pipeline for multiplexed bisulfite sequencing. BMC Genomics 2014; 15: 290.
31. Ernst C, McGowan PO, Deleva V, Meaney MJ, Szyf M, Turecki G. The effects of pH on DNA methylation state: In vitro and post-mortem brain studies. J Neurosci Methods 2008; 174: 123-125.
32. Krueger F, Andrews SR. Bismark: A flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics 2011; 27: 1571-1572.
33. Chen ES, Gigek CO, Rosenfeld JA, Diallo AB, Maussion G, Chen GG et al. Molecular convergence of neurodevelopmental disorders. Am J Hum Genet 2014; 95: 490-508.
34. Geula S, Moshitch-Moshkovitz S, Dominissini D, Mansour AA, Kol N, Salmon-Divon M et al. Stem cells. m6A mRNA methylation facilitates resolution of naive pluripotency toward differentiation. Science 2015; 347: 1002-1006.
35. Fury W, Batliwalla F, Gregersen PK, Li W. Overlapping probabilities of top ranking gene lists, hypergeometric distribution, and stringency of gene selection criterion. Conf Proc IEEE Eng Med Biol Soc 2006; 1: 5531-5534.
36. Friedlander DR, Milev P, Karthikeyan L, Margolis RK, Margolis RU, Grumet M. The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth. J Cell Biol 1994; 125: 669-680.
37. Bae BI, Tietjen I, Atabay KD, Evrony GD, Johnson MB, Asare E et al. Evolutionarily dynamic alternative splicing of GPR56 regulates regional cerebral cortical patterning. Science 2014; 343: 764-768.
38. Stefaniuk M, Swiech L, Dzwonek J, Lukasiuk K. Expression of Ttyh1, a member of the Tweety family in neurons in vitro and in vivo and its potential role in brain pathology. J Neurochem 2010; 115: 1183-1194.
39. Shiihara T, Watanabe M, Moriyama K, Uematsu M, Sameshima K. A novel PLP1 frameshift mutation causing a milder form of Pelizaeus-Merzbacher disease. Brain Dev 2014; 37: 455-458.
40. Schulz DM, Kalkhof S, Schmidt A, Ihling C, Stingl C, Mechtler K et al. Annexin A2/ P11 interaction: New insights into annexin A2 tetramer structure by chemical crosslinking, high-resolution mass spectrometry, and computational modeling. Proteins 2007; 69: 254-269.
41. Jacovina AT, Zhong F, Khazanova E, Lev E, Deora AB, Hajjar KA. Neuritogenesis and the nerve growth factor-induced differentiation of PC-12 cells requires annexin II-mediated plasmin generation. J Biol Chem 2001; 276: 49350-49358.
42. Sun D, Lee YS, Malhotra A, Kim HK, Matecic M, Evans C et al. miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation. Cancer Res 2011; 71: 1313-1324.
43. Victor MB, Richner M, Hermanstyne TO, Ransdell JL, Sobieski C, Deng PY et al. Generation of human striatal neurons by microRNA-dependent direct conversion of fibroblasts. Neuron 2014; 84: 311-323.
44. Liao WT, Ye YP, Zhang NJ, Li TT, Wang SY, Cui YM et al. MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2. J Pathol 2014; 232: 415-427.
45. Sharifi M, Salehi R, Gheisari Y, Kazemi M. Inhibition of microRNA miR-92a induces apoptosis and inhibits cell proliferation in human acute promyelocytic leukemia through modulation of p63 expression. Mol Biol Rep 2014; 41: 2799-2808.
46. Sudhof TC. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008; 455: 903-911.
47. Jeon SJ, Kim JW, Kim KC, Han SM, Go HS, Seo JE et al. Translational regulation of NeuroD1 expression by FMRP: Involvement in glutamatergic neuronal differentiation of cultured rat primary neural progenitor cells. Cell Mol Neurobiol 2014; 34: 297-305.
48. Gong X, Zhang K, Wang Y, Wang J, Cui Y, Li S et al. MicroRNA-130b targets Fmr1 and regulates embryonic neural progenitor cell proliferation and differentiation. Biochem Biophys Res Commun 2013; 439: 493-500.
49. Scotto-Lomassese S, Nissant A, Mota T, Neant-Fery M, Oostra BA, Greer CA et al. Fragile X mental retardation protein regulates new neuron differentiation in the adult olfactory bulb. J Neurosci 2011; 31: 2205-2215.
50. Callan MA, Cabernard C, Heck J, Luois S, Doe CQ, Zarnescu DC. Fragile X protein controls neural stem cell proliferation in the Drosophila brain. Hum Mol Genet 2010; 19: 3068-3079.
51. Castren M, Tervonen T, Karkkainen V, Heinonen S, Castren E, Larsson K et al. Altered differentiation of neural stem cells in fragile X syndrome. Proc Natl Acad Sci USA 2005; 102: 17834-17839.
52. Li H, Zhong X, Chau KF, Santistevan NJ, Guo W, Kong G et al. Cell cycle-linked MeCP2 phosphorylation modulates adult neurogenesis involving the Notch signalling pathway. Nat Commun 2014; 5: 5601.
53. Magri L, Cambiaghi M, Cominelli M, Alfaro-Cervello C, Cursi M, Pala M et al. Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions. Cell Stem Cell 2011; 9: 447-462.
54. Mandel S, Spivak-Pohis I, Gozes I. ADNP differential nucleus/cytoplasm localization in neurons suggests multiple roles in neuronal differentiation and maintenance. J Mol Neurosci 2008; 35: 127-141.
55. Pascual M, Guerri C. The peptide NAP promotes neuronal growth and differentiation through extracellular signal-regulated protein kinase and Akt pathways, and protects neurons co-cultured with astrocytes damaged by ethanol. J Neurochem 2007; 103: 557-568.
56. Kawaguchi D, Yoshimatsu T, Hozumi K, Gotoh Y. Selection of differentiating cells by different levels of delta-like 1 among neural precursor cells in the developing mouse telencephalon. Development 2008; 135: 3849-3858.
57. Chenn A, Walsh CA. Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science 2002; 297: 365-369.
58. Tuoc TC, Boretius S, Sansom SN, Pitulescu ME, Frahm J, Livesey FJ et al. Chromatin regulation by BAF170 controls cerebral cortical size and thickness. Dev Cell 2013; 25: 256-269.
59. Mendez-Gomez HR, Vergano-Vera E, Abad JL, Bulfone A, Moratalla R, de Pablo F et al. The T-box brain 1 (Tbr1) transcription factor inhibits astrocyte formation in the olfactory bulb and regulates neural stem cell fate. Mol Cell Neurosci 2011; 46: 108-121.
60. Valli E, Trazzi S, Fuchs C, Erriquez D, Bartesaghi R, Perini G et al. CDKL5, a novel MYCN-repressed gene, blocks cell cycle and promotes differentiation of neuronal cells. Biochim Biophys Acta 2012; 1819: 1173-1185.
61. Zhu G, Chow LM, Bayazitov IT, Tong Y, Gilbertson RJ, Zakharenko SS et al. Pten deletion causes mTorc1-dependent ectopic neuroblast differentiation without causing uniform migration defects. Development 2012; 139: 3422-3431.
62. Nishiyama M, Skoultchi AI, Nakayama KI. Histone H1 recruitment by CHD8 is essential for suppression of the Wnt-beta-catenin signaling pathway. Mol Cell Biol 2012; 32: 501-512.
63. Flores-Alcantar A, Gonzalez-Sandoval A, Escalante-Alcalde D, Lomeli H. Dynamics of expression of ARID1A and ARID1B subunits in mouse embryos and in cells during the cell cycle. Cell Tissue Res 2011; 345: 137-148.
64. Fukai R, Hiraki Y, Yofune H, Tsurusaki Y, Nakashima M, Saitsu H et al. A case of autism spectrum disorder arising from a de novo missense mutation in POGZ. J Hum Genet 2015; doi: 10.1038/jhg.2015.13; e-pub ahead of print 19 February 2015.
65. Nozawa RS, Nagao K, Masuda HT, Iwasaki O, Hirota T, Nozaki N et al. Human POGZ modulates dissociation of HP1alpha from mitotic chromosome arms through Aurora B activation. Nat Cell Biol 2010; 12: 719-727.
66. Nicetto D, Hahn M, Jung J, Schneider TD, Straub T, David R et al. Suv4-20 h histone methyltransferases promote neuroectodermal differentiation by silencing the pluripotency-associated Oct-25 gene. PLoS Genet 2013; 9: E1003188.
67. Yang G, Smibert CA, Kaplan DR, Miller FD. An eIF4E1/4E-T complex determines the genesis of neurons from precursors by translationally repressing a proneurogenic transcription program. Neuron 2014; 84: 723-739.
68. Schuetz G, Rosario M, Grimm J, Boeckers TM, Gundelfinger ED, Birchmeier W. The neuronal scaffold protein Shank3 mediates signaling and biological function of the receptor tyrosine kinase Ret in epithelial cells. J Cell Biol 2004; 167: 945-952.
69. Zeng L, Zhang P, Shi L, Yamamoto V, Lu W, Wang K. Functional impacts of NRXN1 knockdown on neurodevelopment in stem cell models. PLoS One 2013; 8: E59685.
70. Shi L, Chang X, Zhang P, Coba MP, Lu W, Wang K. The functional genetic link of NLGN4X knockdown and neurodevelopment in neural stem cells. Hum Mol Genet 2013; 22: 3749-3760.
71. Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, Fossdal R et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008; 358: 667-675.
72. Mefford HC, Sharp AJ, Baker C, Itsara A, Jiang Z, Buysse K et al. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med 2008; 359: 1685-1699.
73. Sheridan SD, Theriault KM, Reis SA, Zhou F, Madison JM, Daheron L et al. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLoS One 2011; 6: E26203.
74. Djuric U, Cheung AY, Zhang W, Mok RS, Lai W, Piekna A et al. MECP2e1 isoform mutation affects the form and function of neurons derived from Rett syndrome patient iPS cells. Neurobiol Dis 2015; 76C: 37-45.
75. Hanson E, Nasir RH, Fong A, Lian A, Hundley R, Shen Y et al. Cognitive and behavioral characterization of 16p11.2 deletion syndrome. J Dev Behav Pediatr 2010; 31: 649-657.
76. Dolcetti A, Silversides CK, Marshall CR, Lionel AC, Stavropoulos DJ, Scherer SW et al. 1q21.1 Microduplication expression in adults. Genet Med 2013; 15: 282-289.
77. Golzio C, Willer J, Talkowski ME, Oh EC, Taniguchi Y, Jacquemont S et al. KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant. Nature 2012; 485: 363-367.
78. Pucilowska J, Vithayathil J, Tavares EJ, Kelly C, Karlo JC, Landreth GE. The 16p11.2 Deletion Mouse Model of Autism Exhibits Altered Cortical Progenitor Proliferation and Brain Cytoarchitecture Linked to the ERK MAPK Pathway. J Neurosci 2015; 35: 3190-3200.
79. Wang B, Gao Y, Xiao Z, Chen B, Han J, Zhang J et al. Erk1/2 promotes proliferation and inhibits neuronal differentiation of neural stem cells. Neurosci Lett 2009; 461: 252-257.
80. Chen M, Huang JD, Hu L, Zheng BJ, Chen L, Tsang SL et al. Transgenic CHD1L expression in mouse induces spontaneous tumors. PLoS One 2009; 4: E6727.
81. Mani M, Carrasco DE, Zhang Y, Takada K, Gatt ME, Dutta-Simmons J et al. BCL9 promotes tumor progression by conferring enhanced proliferative, metastatic, and angiogenic properties to cancer cells. Cancer Res 2009; 69: 7577-7586.